Bioenhancing effects of piperine and curcumin on triterpenoid pharmacokinetics and neurodegenerative metabolomes from Centella asiatica extract in beagle dogs
Open Access
- 1 December 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-14
Abstract
Centell-S is a water-soluble extract ofCentella asiaticacontaining more than 80% w/w triterpenoid glycosides. Madecassoside and asiaticoside are two major components of the extract and can be converted into active metabolites, triterpenic acids in large mammal species. In this study, the pharmacokinetic profiles and metabolomic changes generated by the bioactive triterpenoids of Centell-S alone, and in combination with the bioenhancers piperine and curcumin, were investigated in beagle dogs. The test substances were orally administered over multiple doses for 7 consecutive days. At day 1 and 7 after receiving the test compounds, the level of major bioactive triterpenoids and related metabolites were measured using triple quadrupole and high-resolution accurate mass orbitrap models of LCMS to determine pharmacokinetic and metabolomic profiles, respectively. Centell-S was well tolerated, alone and in all combination groups. The combination of Centell-S and piperine significantly increased (p < 0.05) the systemic exposure of madecassoside on day 1 and asiatic acid on day 7, by approximately 1.5 to 3.0-fold of Cmaxand AUC values as compared to the Centell-S alone, while the addition of curcumin did not provide a significant improvement. Several metabolomic changes were observed from pre-dose to 4 h post-dose, with some biomarkers of neurodegenerative diseases includingl-glutamine, lysophosphatidylcholine (17:0), taurochenodeoxycholic acid, uric acid, stearic acid, palmitic acid, and lactic acid showing good correlation with the systemic exposure of the bioactive triterpenoids (asiatic acid). Thus, the combining of piperine to Centell-S exhibits the improvement of bioactive triterpenoids which are related to the biomarkers of neurodegenerative diseases. These promising results might be useful for the development of this standardised extract to become a more effective phytomedicine for neurodegenerative diseases.Keywords
Funding Information
- the Second Century Fund (C2F), Chulalongkorn University for Postdoctoral Fellowship, Chulalongkorn University
- Siam Herbal Innovation Company Limited
This publication has 81 references indexed in Scilit:
- Bioavailability enhancers of herbal origin: An overviewAsian Pacific Journal of Tropical Biomedicine, 2013
- Glutamine Acts as a Neuroprotectant against DNA Damage, Beta-Amyloid and H2O2-Induced StressPLOS ONE, 2012
- A Comprehensive Review on Pharmacotherapeutics of Herbal BioenhancersThe Scientific World Journal, 2012
- High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratioProceedings of the National Academy of Sciences of the United States of America, 2010
- Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbitsJournal of Veterinary Science, 2009
- Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoproteinLife Sciences, 2008
- Metabolomics of Neural Progenitor Cells: A Novel Approach to Biomarker DiscoveryCold Spring Harbor Symposia on Quantitative Biology, 2008
- Targeted Profiling: Quantitative Analysis of 1H NMR Metabolomics DataAnalytical Chemistry, 2006
- Asiatic acid derivatives enhance cognitive performance partly by improving acetylcholine synthesisJournal of Pharmacy and Pharmacology, 2004
- Long-term potentiation in the hippocampus induced by platelet-activating factorNeuron, 1993